Calcium
Alzheimer Disease (AD)
Rune Skovgaard RasmussenSmall moleculePhase 2Active
CCC
53/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 38/ 100
- Competitive Position
- 89/ 100
Competitive context
7 Active assets in the Alzheimer Disease (AD) cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
LECANEMAB Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 4 | BB |
Zagotenemab Eli Lilly and Company | Phase 2 | B |
CANDESARTAN Rune Skovgaard Rasmussen | Phase 2 | CCC |
ARA-GUANOSINE CellSight Technologies, Inc. | Phase 2 | CCC |
18f-op-801 Ashvattha Therapeutics, Inc. | Phase 1/2 | CC |
Protollin Brigham and Women's Hospital | Phase 1 | CC |
Umbilical Cord Blood Mononuclear Cells Anhui Provincial Hospital | Early Phase 1 | C |
Neural Stem Cell-Derived Exosomes Shanghai Mental Health Center | Phase 1 | NR |
Same molecule, other indications
Calcium is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →